Kalaris Therapeutics, Inc.
KLRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001754068
No open-market purchases or sales by Kalaris Therapeutics, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $73.4M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Kalaris Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 82
- −8 vs. Q3 2023
- Shares held
- 41.9M
- −11.8M (−22.0%) vs. Q3 2023
- Total value
- $28.5M
- −$87.0M (−75.3%) vs. Q3 2023
- New holders
- 26
- 21 more added
- Sold out
- 34
- 22 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KLRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $73.4M |
| Q1 2026 | 58 | $107.2M |
| Q4 2025 | 51 | $151.9M |
| Q3 2025 | 32 | $76.4M |
| Q2 2025 | 30 | $35.7M |
| Q1 2025 | 32 | $111.4M |
| Q4 2024 | 53 | $20.7M |
| Q3 2024 | 60 | $36.3M |
| Q2 2024 | 72 | $33.9M |
| Q1 2024 | 77 | $36.4M |
| Q4 2023 | 82 | $28.5M |
| Q3 2023 | 90 | $115.5M |
| Q2 2023 | 94 | $183.6M |
| Q1 2023 | 89 | $156.0M |
| Q4 2022 | 86 | $193.1M |
| Q3 2022 | 87 | $293.7M |
| Q2 2022 | 84 | $109.6M |
| Q1 2022 | 84 | $184.1M |
| Q4 2021 | 84 | $329.4M |
| Q3 2021 | 80 | $640.3M |
| Q2 2021 | 84 | $521.8M |
| Q1 2021 | 75 | $624.4M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Kalaris Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SEI Investments Co | 0 | $0 | 0.00% | −19,698−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −18,974−100.0% | Sold out |
| SVB Financial Group | 0 | $0 | 0.00% | −17,207−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −14,791−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −14,544−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −14,057−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −13,508−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −10,720−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,099−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −3,030−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −2,917−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −1,972−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,665−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −625−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −375−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −442−100.0% | Sold out |